Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Development of a Seizure Detection Algorithm Based on Heart Rate and Movement Analysis
A completed clinical trial evaluating a seizure detection algorithm that analyzes heart rate and movement data to identify seizures in epile…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Assessment of Kidney Function in Patients With Epilepsy
A Sohag University-sponsored clinical trial is assessing kidney function in patients with epilepsy and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Predictors of Drug Resistant Epilepsy Among Pediatric Patients
This clinical trial aims to identify predictors of drug-resistant epilepsy in pediatric patients; enrollment has not yet begun.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Clinical Trial of Vormatrigine in Adult Patients With Epilepsy [Phase 3]
Phase 3 clinical trial of Vormatrigine in adult patients with epilepsy is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)
This clinical trial assesses the use of tripolar EEG (tEEG) technology to detect seizures in people with epilepsy, and the study is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Electrochemical and Electrophysiological Study [NA]
Clinical trial update for an electrochemical and electrophysiological study sponsored by the University of Arizona, investigating cognition …
-
EMA approval · 2025-12-16EMA Authorised: Matever (levetiracetam) — Pharmathen S.A.
The EMA authorised Matever (levetiracetam) by Pharmathen S.A. for the treatment of epilepsy. Decision date: 16 December 2025.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs [NA]
A Duke University-led clinical trial is exploring sleep-sensitive seizure risk using wearable EEGs in individuals with intractable epilepsy;…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Pro-Epileptic Effects of IV Ketamine [Phase 4]
Phase 4 trial results indicate pro-epileptic effects associated with intravenous ketamine in individuals with epilepsy and seizures. The stu…
-
EMA approval · 2025-12-15EMA Authorised: Levetiracetam Hospira (levetiracetam) — Pfizer Europe MA EEIG
The EMA has granted marketing authorization for Levetiracetam Hospira (levetiracetam) as a generic anti-epileptic drug for epilepsy, with Pf…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: High-density EEG in Neurological Disorders [NA]
A completed clinical trial evaluating high-density EEG in neurological disorders has posted its results, with epilepsy and brain tumor as co…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures [Phase 2]
An open-label extension of CVL-865 evaluated as adjunctive therapy for focal onset seizures in a Phase 2 study; the trial was terminated and…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
This entry describes a clinical trial evaluating outcomes of a Modified Atkins Diet in pediatric patients with drug-resistant epilepsy; the …
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: National Survey on Physical and Sports Activity of Adults With Epilepsy
A national survey evaluating physical and sports activity in adults with epilepsy, sponsored by Fondation Ophtalmologique Adolphe de Rothsch…
-
EMA approval · 2025-12-09EMA Authorised: Levetiracetam Accord (levetiracetam) — Accord Healthcare S.L.U.
The EMA authorised Levetiracetam Accord for epilepsy, granting EU marketing authorization to Accord Healthcare S.L.U.
-
FDA approval · 2025-12-04FDA Approved: TOPIRAMATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals' supplemental application for Topiramate, enabling a generic version of this anticonvulsant. The a…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis [NA]
A planned clinical trial in Ibadan, Nigeria will evaluate whether medical TV drama can improve health literacy about neurocysticercosis and …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy [NA]
A completed clinical trial evaluating the influence of intermittent fasting with and without medium-chain triglycerides in patients with dru…
-
EMA withdrawal · 2025-12-04EMA Application withdrawn: Tuzodi (Midazolam Hydrochloride) — Regulatory Pharma Net S.r.l.
The EMA has withdrawn the application for Tuzodi (Midazolam Hydrochloride) by Regulatory Pharma Net S.r.l., for seizures.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Compassion Focussed Therapy Informed Psychoeducation and Loving Kindness Meditation for Young People With Epilepsy [NA]
This ClinicalTrials.gov update describes a compassionate-focused therapy and loving-kindness meditation intervention for young people with e…
-
EMA approval · 2025-12-03EMA Authorised: Ontozry (cenobamate) — Angelini Pharma S.p.A
The EMA has authorised Ontozry (cenobamate) from Angelini Pharma S.p.A. for epilepsy in the European Union, with decision dated 17 November …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug
The entry notes that the national study evaluating EEG-fMRI for presurgical evaluation of partial epilepsies has completed.
-
EMA approval · 2025-12-02EMA Authorised: Pregabalin Sandoz (pregabalin) — Sandoz GmbH
The EMA authorised the Sandoz generic pregabalin product for anxiety disorders, neuralgia, and epilepsy.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: U011 - Wireless Ultra Long-Term EEG Recordings in Epilepsy [NA]
An update on a clinical trial evaluating wireless ultra long-term EEG recordings in epilepsy; the study is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Recording "Fast Ripples" Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy [NA]
A completed clinical trial evaluating recording fast ripples with microelectrodes during stereo-encephalography in people with drug-resistan…